首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance
【2h】

Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance

机译:体内施用抗CTLA-4单克隆抗体和IL-12对诱导小剂量口服耐受的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral tolerance has been characterized as an immunological hyporesponsiveness to fed antigen. Previous studies have suggested that high-dose oral tolerance involves the preferential interaction of B7 with CTLA-4 on the T cell. To determine whether similar mechanisms are involved in the induction of low-dose oral tolerance, mice were treated with anti-CTLA-4 monoclonal antibody (MoAb), with or without IL-12, at the time of feeding. Results showed that anti-CTLA-4 MoAb alone failed to restore cellular proliferation, antibody titres and IFN-γ levels; however, IL-4 cytokine levels in OVA-fed mice were partially restored. In contrast, administration of IL-12 along with anti-CTLA-4 MoAb to mice during feeding completely prevented the suppression of Th1 immune responses, as shown by increased serum IgG2a titres, IFN-γ production and cell proliferation. These results suggest that blocking B7-CTLA-4 interactions in the presence of IL-12 prevents the induction of low-dose oral tolerance at the Th1 cell level.
机译:口服耐受已被表征为对进食抗原的免疫学低反应性。先前的研究表明,大剂量口服耐受性涉及B7与T细胞上CTLA-4的优先相互作用。为了确定低剂量口服耐受性的诱导是否涉及类似的机制,在喂养时用抗CTLA-4单克隆抗体(MoAb),有或没有IL-12对小鼠进行了治疗。结果表明,单独使用抗CTLA-4 MoAb不能恢复细胞增殖,抗体滴度和IFN-γ水平。但是,OVA喂养的小鼠的IL-4细胞因子水平得以部分恢复。相比之下,喂食过程中向小鼠施用IL-12和抗CTLA-4 MoAb完全抑制了Th1免疫应答的抑制,这表现为血清IgG2a滴度增加,IFN-γ产生和细胞增殖。这些结果表明,在IL-12存在下阻断B7-CTLA-4相互作用可防止在Th1细胞水平上诱导低剂量口服耐受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号